AstraZeneca CEO on drug prices: The system has to change

By Health CareFOXBusiness

AstraZeneca CEO on drug prices

AstraZeneca CEO Pascal Soriot on the decline in interest rates, U.S. trade tensions with China and efforts to lower drug prices in the U.S.

As part of the Trump administration’s broader efforts to reform health care, President Trump has lead a push to lower drug prices for U.S. consumers, but it is uncertain how the potential reforms will impact pharmaceutical companies. 

Continue Reading Below

AstraZeneca CEO Pascal Soriot weighed in telling the FOX Business ‘Varney & Co.’, “We may be [affected], I mean, actually nobody knows what the outcome of the discussions will be.”

MORE FROM FOXBUSINESS.COM...

The Senate is also trying to tackle drug prices with the Prescription Drug Pricing Reduction Act proposal.

“The package that is going through Senate, some aspects are good, some aspects are not reasonable, we believe, but there are some good things and the system has to change,” Soriot said.

CLICK HERE TO GET THE FOX BUSINESS APP